Apr 24, 2025 4:15pm EDT Ensysce Biosciences, Inc. Announces Closing of Exercise of Warrants for $2.2 Million Gross Proceeds
Apr 23, 2025 4:41pm EDT Ensysce Biosciences, Inc. Announces Exercise of Warrants for $2.2 Million Gross Proceeds
March 3, 2025 Ensysce Biosciences CEO Dr. Lynn Kirkpatrick and Creighton University's Dr. Neel Pathak Discuss the Opioid Crisis and Next Generation Opioids
December 20, 2023 Navigating the Future of Pain Management: Ensysce Biosciences’ Innovative Approach